For the trials, programs, and indications where dose precision matters

Pharma · Medical Affairs & HEOR

Phase 4 and post-marketing evidence demands measurement-grade data

Real-world adherence data generated from proxy-event sensors carries an interpretive footnote in every analysis. Quantity-level data does not. MyAide produces a measurement record that can be cleanly stratified, modeled, and defended in HEOR analyses, registries, post-authorization safety studies, and label-expansion evidence packages.

The downstream effect on the analysis itself is substantial. Quantity-level data supports clean stratification by adherence quartile, defensible dose-response and exposure-response modeling, and persistence curves built on what patients actually took rather than what a cap opening implied. For evidence packages that go to payers, regulators, or formulary committees, the difference is whether adherence appears as a confounder to be hedged against or as a variable that strengthens the argument.

Clinical Trials & CROs

Trial-grade adherence data without site burden

Bluetooth and WiFi-connected hardware, no patient app required, and a sponsor dashboard that delivers the data directly. Validated to 100% pill-count agreement and 99% time-of-administration accuracy, defensible in protocol-deviation review and primary-endpoint sensitivity analyses, with CDISC/SDTM-compliant output.

One device on the patient’s countertop, no app for sites to support, and no separate data stream for the CRA to reconcile. Bluetooth and WiFi avoid the IT and consent friction that cellular devices create, and the sponsor sees the same record the site sees.

Specialty Pharmacy & Health Systems

Adherence data your pharmacists can act on the same day

MyAide flags partial doses, missed doses, late doses, and double doses at the patient level, not month-end claims aggregates. Clinical pharmacists can intervene during the actual gap, not after a refill has lapsed.

RPM Platforms & Adherence Coaching

The medication signal your outcomes model is missing

MyAide is built to fit inside an RPM platform as a medication intelligence layer, across both chronic disease management and narrow-therapeutic-index medications. The app supports the patient at the point of dosing and complements a platform's own patient experience rather than competing with it. The hardware connects over Bluetooth and WiFi without cellular friction, and the data exports in CDISC/SDTM form, so the sensor-verified dose signal enters an existing model and workflow as a clean input rather than another system to manage.

Dermatology · Pharma & Trials

We measure topical adherence, across parameters

Sensal is the only adherence platform with validated measurement across the full range of dermatology dosage forms: oral solids on the Smart Dock, and foams, gels, creams, and ointments on the Smart Cap and Smart Dock. Patients have used the technology as part of their daily routine without changing how they apply or take medication, and the platform captures how much was dispensed at each use and when. The result is a clean quantity-level adherence record for sponsors evaluating biologics-versus-topicals positioning, for trials where topical arms have historically been weakened by uncertain adherence, and for specialty programs supporting psoriasis, atopic dermatitis, and acne.